+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up)



Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up)



International Journal of Oral and Maxillofacial Surgery 23(3): 140-148



A multicentric, randomized study of squamous cell carcinoma (SCC) of the oral cavity and the oropharynx has been undertaken by DOSAK. The results after radical surgery alone have been compared with the results of combined preoperative radiochemotherapy followed by radical surgery. Patients with primary (biopsy proven) SCC of the oral cavity or the oropharynx with tumor nodes metastasis (TNM) stages T2-4, N0-3, M0 were included in the study. A total of 141 patients were treated by radical surgery alone, whereas 127 patients were treated by radical surgery preceded by preoperative radiochemotherapy. The preoperative treatment consisted of conventionally fractioned irradiation on the primary and the regional lymph nodes with a total dose of 36 Gy (5 x 2 Gy per week) and low-dose cisplatin chemotherapy with 5 x 12.5 mg cisplatin per m2 of body surface during the first week of treatment. Radical surgery according to the DOSAK definitions (DOSAK, 1982) was performed after a delay of 10-14 days. During the follow-up period, 28.2% of all patients suffered from locoregional recurrence, and 27.2% of the patients died. The percentages were higher after radical surgery alone for locoregional recurrence (31% and 15.6%) and for death (28% and 18.6%). The life-table analysis showed improved survival rates of 4.5% after 1 year and 8.3% after 2 years in the group of patients treated with combined therapy. The demonstrated improvement appeared to be significant with the Gehan-Wilcoxon test as well as with the log rank test below a P value of 5%.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047050451

Download citation: RISBibTeXText

PMID: 7930766


Related references

Preoperative radio-chemotherapy and radical surgery for advanced carcinomas of the oral cavity. 4-year results of a prospective therapy study with DOSAK. Deutsche Zeitschrift für Mund- Kiefer- und Gesichts-Chirurgie 14(4): 242-249, 1990

Five year survival rate of patients with squamous cell carcinoma of the oral cavity a comparison of two groups of patients radical surgery plus postoperative radiotherapy vs preoperative chemotherapy plus radical surgery. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 1): 696, 1990

Preoperative radiochemotherapy and radical surgery of advanced head and neck cancers--results of a prospective, multicenter DOSAK study. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 134: 155-163, 1994

Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results. Oral Oncology 35(6): 597-606, 1999

Preoperative irradiation, cisplatin sensitization and radical surgery of primarily operable carcinomas of the oral cavity. Results of a prospective DOSAK treatment study. Deutsche Zeitschrift für Mund- Kiefer- und Gesichts-Chirurgie 13(5): 338-344, 1989

Introduction to the "Prospective DOSAK Study on Squamous Cell Carcinoma of the Lips, the Oral Cavity and the Oropharynx". Deutsche Zeitschrift für Mund-, Kiefer- und Gesichts-Chirurgie 12(4): 293-302, 1988

The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery. Journal of Cranio-Maxillo-Facial Surgery 41(1): 22-27, 2013

Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients. Strahlentherapie und Onkologie 184(1): 23-29, 2008

Advanced squamous cell carcinoma of the oral cavity and oropharynx treated with irradiation and surgery. Radiology 119(2): 433-438, 1976

Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity - Outcome of 134 patients FT Neoadjuvante Radiochemotherapie und radikale Resektion bei fortgeschrittenen Plattenepithelkarzinomen der mundhohle. Behandlungsergebnisse von 134 patienten. 2008

Randomized phase III trial in locally advanced squamous cell carcinoma of the esophagus: Neoadjuvant radiochemotherapy followed by surgery vs. definitive radiochemotherapy. International Journal of Radiation Oncology*biology*physics 60: S139-S139, 2004

Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. International Journal of Oral & Maxillofacial Surgery 23(3): 140-148, 1994

Critical evaluation of the treatment-dependent prognosis index TPI based on the "prospective DOSAK study on squamous cell carcinomas of the lips, oral cavity and oropharynx". Deutsche Zeitschrift für Mund- Kiefer- und Gesichts-Chirurgie 13(5): 329-337, 1989

Preoperative radiochemotherapy for advanced oral cavity tumours : the Kiel DOSAK experience regarding curability and quality of life. Mund- Kiefer- und Gesichtschirurgie 10(4): 249-257, 2006

Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Annals of Surgical Oncology 16(1): 159-170, 2009